Clincosm LogoSign in Get a demo

diffuse large b cell lymphoma

Showing 101 - 125 of 206
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

The Potential of Patient-reported Outcome Measures in Detection

Recruiting
  • Diffuse Large B Cell Lymphoma
  • Patient Reported Outcome
  • No intervention
  • Copenhagen, Denmark
    Therese Lassen
Mar 18, 2022

Non Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma Trial in Nanjing, Nanjin (Zanubrutinib, Lenalidomide, Rituximab)

Recruiting
  • Non Hodgkin Lymphoma
  • Diffuse Large B Cell Lymphoma
  • Nanjing, Jiangsu, China
  • +1 more
Mar 9, 2022

Diffuse Large B Cell Lymphoma Trial in Italy (Treatment plan)

Completed
  • Diffuse Large B Cell Lymphoma
  • Treatment plan
  • Milano, MI, Italy
  • +18 more
Feb 15, 2022

Immune Responses to COVID-19 Vaccination in Lymphoma Patients

Active, not recruiting
  • Classical Hodgkin Lymphoma
  • +12 more
    • Bedford, Bedfordshire, United Kingdom
    • +8 more
    Feb 22, 2022

    Diffuse Large B Cell Lymphoma, Follicular Lymphoma Trial in Brisbane, Clayton, Heidelberg (Durvalumab, Radiotherapy,

    Recruiting
    • Diffuse Large B Cell Lymphoma
    • Follicular Lymphoma
    • Brisbane, Queensland, Australia
    • +2 more
    Feb 14, 2022

    Squamous Cell Carcinoma of the Head and Neck, Melanoma, Non Small Cell Lung Cancer Trial in Worldwide (SL-279252)

    Recruiting
    • Squamous Cell Carcinoma of the Head and Neck
    • +12 more
    • Nashville, Tennessee
    • +4 more
    Feb 3, 2022

    Hodgkin Lymphoma, NK/T Cell Lymphoma, Peripheral T Cell Lymphoma, Unspecified Trial in Hangzhou (Anti CD30 CAR-T Cell Injection)

    Not yet recruiting
    • Hodgkin Lymphoma
    • +7 more
    • Anti CD30 CAR-T Cell Injection
    • Hangzhou, Zhejiang, China
      The First Affiliated Hospital, College of medicine, Zhejiang Uni
    Jan 12, 2022

    Diffuse Large B Cell Lymphoma, High-grade B-cell Lymphoma, Transformed Lymphoma Trial in China (Rituximab, Etoposide,

    Recruiting
    • Diffuse Large B Cell Lymphoma
    • +2 more
    • Changsha, Hunan, China
    • +5 more
    Jan 24, 2022

    Diffuse Large B Cell Lymphoma, CD79A Gene Mutation, CD79B Gene Mutation Trial in Zhengzhou (Rituximab, Zanubrutinib,

    Recruiting
    • Diffuse Large B Cell Lymphoma
    • +2 more
    • Zhengzhou, Henan, China
      Henan Cancer Hospital/The affiliated Cancer Hospital of ZhengZho
    Jan 22, 2022

    Diffuse Large B Cell Lymphoma, Follicular Lymphoma, Mantle Cell Lymphoma Trial in Hefei, Nanjing, Beijing (LUCAR-20S CAR-T

    Terminated
    • Diffuse Large B Cell Lymphoma
    • +3 more
    • LUCAR-20S CAR-T cells
    • Hefei, Anhui, China
    • +2 more
    Dec 17, 2021

    Diffuse Large B Cell Lymphoma Trial in Poland (Ofatumumab, Etoposide, Ifosfamid)

    Completed
    • Diffuse Large B Cell Lymphoma
    • Wrocław, Dolnośląskie, Poland
    • +7 more
    Dec 23, 2021

    Predict CNS Involvement in Diffuse Large B-Cell Lymphoma:Danish

    Completed
    • Diffuse Large B Cell Lymphoma
    • +2 more
      • (no location specified)
      Dec 13, 2021

      High Grade B-Cell Lymphoma, Not Otherwise Specified, High Grade B-Cell Lymphoma With MYC and BCL2 and/or BCL6 Rearrangements,

      Recruiting
      • High Grade B-Cell Lymphoma, Not Otherwise Specified
      • +4 more
      • Zanubrutinib+R-CHOP; Zanubrutinib+R-DA-EPOCH; Zanubrutinib+R-HD MTX
      • R-CHOP; R-DA-EPOCH; R-HD MTX
      • Jinan, Shandong, China
        Department of Hematology, Shandong Provincial Hospital
      Dec 7, 2021

      Hematologic Diseases, Acute Leukemia in Remission, Chronic Myelogenous Leukemia - Chronic Phase Trial in Ann Arbor (Vorinostat,

      Recruiting
      • Hematologic Diseases
      • +11 more
      • Ann Arbor, Michigan
        University of Michigan Health System
      Dec 2, 2021

      Diffuse Large B Cell Lymphoma Trial in Saint Louis (18F-FluorApoTrace)

      Recruiting
      • Diffuse Large B Cell Lymphoma
      • Saint Louis, Missouri
        Washington University School of Medicine
      Dec 7, 2021

      Diffuse Large B Cell Lymphoma (DLBCL)

      Completed
      • Diffuse Large B Cell Lymphoma
      • Biological samples collection
      • Caen, France
      • +14 more
      Dec 6, 2021

      CAR T Cell Therapy Related Cardiovascular Outcomes

      Recruiting
      • Cardiovascular Diseases
      • +7 more
        • London, United Kingdom
          University College London Hospitals
        Nov 18, 2021

        B-cell Lymphoma, Burkitt Lymphoma, Diffuse Large B Cell Lymphoma Trial in Valhalla (Polatuzumab vedotin)

        Recruiting
        • B-cell Lymphoma
        • +8 more
        • Polatuzumab vedotin
        • Valhalla, New York
          New York Medical Center
        Oct 29, 2021

        Diffuse Large B Cell Lymphoma, Mantle Cell Lymphoma, Chronic Lymphocytic Leukemia Trial in Wuhan (BTK inhibitor+ Fludarabine +

        Recruiting
        • Diffuse Large B Cell Lymphoma
        • +4 more
        • BTK inhibitor+ Fludarabine + Cyclophosphamide + CAR-T-CD19 Cells
        • Fludarabine + Cyclophosphamide + CAR-T-CD19 Cells
        • Wuhan, Hubei, China
          Union Hospital, Huazhong University of Science and Technology
        Oct 13, 2021

        Systemic Therapies for R/R DLBCL

        Completed
        • Diffuse Large B Cell Lymphoma
          • Scottsdale, Arizona
          • +165 more
          Oct 12, 2021

          Diffuse Large B Cell Lymphoma Trial in Denmark, Sweden (Idelalisib)

          Completed
          • Diffuse Large B Cell Lymphoma
          • Aarhus C, Denmark
          • +5 more
          Oct 12, 2021

          Diffuse Large B Cell Lymphoma Trial in France (Adapted physical activity)

          Recruiting
          • Diffuse Large B Cell Lymphoma
          • Adapted physical activity
          • Besançon, France
          • +4 more
          Oct 7, 2021

          Diffuse Large B Cell Lymphoma, CNS Lymphoma Trial in Beijing (Methotrexate)

          Recruiting
          • Diffuse Large B Cell Lymphoma
          • Central Nervous System Lymphoma
          • Beijing, Beijing, China
            Peking union medical college hospital
          Sep 21, 2021

          Diffuse Large B Cell Lymphoma, Follicular Lymphoma Grade 3B Trial in Changchun (R-CDOP)

          Recruiting
          • Diffuse Large B Cell Lymphoma
          • Follicular Lymphoma Grade 3B
          • R-CDOP
          • Changchun, Jilin, China
            The First Bethune Hospital of Jilin University
          Sep 15, 2021

          Diffuse Large B Cell Lymphoma Trial (Pembrolizumab and CXD101)

          Withdrawn
          • Diffuse Large B Cell Lymphoma
          • Pembrolizumab and CXD101
          • (no location specified)
          Aug 12, 2021